Wire · opportunities
FDA Approves the First mRNA Flu Vaccine
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 30 August 2026 · Fusion42 review
The U.S. FDA has approved the first mRNA-based flu vaccine, mFlusiva by Moderna, which shows up to 27% greater effectiveness compared to traditional flu vaccines, especially benefiting seniors over 50.
This Wire brief sits within Fusion42's coverage of Health, and 9 sources have reported it between 6 Aug 2026 and 12 Aug 2026.
◆ ◆ The Wire takeaway
This FDA approval opens a faster vaccine innovation path that you can now exploit to outpace incumbents by rapidly adapting to viral changes; traditional flu vaccine makers will lose ground to mRNA technologies.
◆ Coverage
9 sources · first reported 6 Aug 2026 · latest 12 Aug 2026
◆ Related on Wire
◆ Topics